Error: Could not add to watchlist. X

DekaLux-PharmaTech

+ Watchlist
DKXPHCF:LX
281.90
EUR
2.31
0.83%
As of 00:59:30 ET on 07/01/2015.
Volume
0
Previous Close
279.59
52Wk Range
195.33 - 298.22
1 Yr Return
41.07%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/01/2015)
281.9
Total Assets (m EUR) (on 07/01/2015)
343.471
Inception Date
06/02/2008
Last Dividend (on 06/30/2014)
1.2398
Dividend Indicated Gross Yield
0.44%
Fund Managers
-
Front Load Fee
3.75%
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
0.18%
Expense Ratio
1.47%
Top Fund Holdings
Name Position Value % of Fund
Johnson & Johnson 252.00 k 21.80 m 6.97
Novartis AG 204.00 k 15.74 m 5.03
Pfizer Inc 568.00 k 14.64 m 4.68
Roche Holding AG 63.00 k 14.17 m 4.53
Merck & Co Inc 258.00 k 12.23 m 3.91
Gilead Sciences Inc 135.00 k 10.79 m 3.45
Amgen Inc 65.00 k 8.69 m 2.78
Sanofi 106.00 k 8.02 m 2.56
AbbVie Inc 145.00 k 8.00 m 2.56
GlaxoSmithKline PLC 430.00 k 7.65 m 2.45
Profile
DekaLux-PharmaTech is an open-end fund incorporated in Luxembourg. The Fund's objective is growth and income. The Fund invests in global companies involved in growth sectors such as pharmaceuticals, biotechnology, medtech, and healthcare.
ADDRESS
Deka International SA
5, rue des Labours
L-1912 Luxembourg
Luxembourg
PHONE
352-3409-39 Tel
WEBSITE
-